Literature DB >> 27104624

Bacterial azurin in potential cancer therapy.

Ananda M Chakrabarty1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27104624      PMCID： PMC4957595          DOI： 10.1080/15384101.2016.1179034

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  Apoptosis or growth arrest: Modulation of tumor suppressor p53's specificity by bacterial redox protein azurin.

Authors:  Tohru Yamada; Yoshinori Hiraoka; Masateru Ikehata; Kazuhide Kimbara; Benjamin S Avner; Tapas K Das Gupta; Ananda M Chakrabarty
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-24       Impact factor: 11.205

2.  Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth.

Authors:  Anita Chaudhari; Magdy Mahfouz; Arsenio M Fialho; Tohru Yamada; Ana Teresa Granja; Yonghua Zhu; Wataru Hashimoto; Beatrix Schlarb-Ridley; Wonhwa Cho; Tapas K Das Gupta; Ananda M Chakrabarty
Journal:  Biochemistry       Date:  2007-01-24       Impact factor: 3.162

3.  Azurin-like protein blocks invasion of Toxoplasma gondii through potential interactions with parasite surface antigen SAG1.

Authors:  Arunasalam Naguleswaran; Arsenio M Fialho; Anita Chaudhari; Chang Soo Hong; Ananda M Chakrabarty; William J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

4.  High-throughput molecular profiling of a P-cadherin overexpressing breast cancer model reveals new targets for the anti-cancer bacterial protein azurin.

Authors:  Nuno Bernardes; Ana Sofia Ribeiro; Sofia Abreu; André F Vieira; Laura Carreto; Manuel Santos; Raquel Seruca; Joana Paredes; Arsenio M Fialho
Journal:  Int J Biochem Cell Biol       Date:  2014-02-06       Impact factor: 5.085

5.  Azurin, Plasmodium falciparum malaria and HIV/AIDS: inhibition of parasitic and viral growth by Azurin.

Authors:  Anita Chaudhari; Arsenio M Fialho; Deena Ratner; Phalguni Gupta; Chang Soo Hong; Soumen Kahali; Tohru Yamada; Kasturi Haldar; Sean Murphy; Wonhwa Cho; Virander S Chauhan; Tapas K Das Gupta; Ananda M Chakrabarty
Journal:  Cell Cycle       Date:  2006-08-01       Impact factor: 4.534

6.  Modulation of membrane properties of lung cancer cells by azurin enhances the sensitivity to EGFR-targeted therapy and decreased β1 integrin-mediated adhesion.

Authors:  Nuno Bernardes; Sofia Abreu; Filomena A Carvalho; Fábio Fernandes; Nuno C Santos; Arsénio M Fialho
Journal:  Cell Cycle       Date:  2016-04-20       Impact factor: 4.534

7.  A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours.

Authors:  M A Warso; J M Richards; D Mehta; K Christov; C Schaeffer; L Rae Bressler; T Yamada; D Majumdar; S A Kennedy; C W Beattie; T K Das Gupta
Journal:  Br J Cancer       Date:  2013-02-28       Impact factor: 7.640
  7 in total
  6 in total

1.  Synergistic effect of granzyme B-azurin fusion protein on breast cancer cells.

Authors:  Nafiseh Paydarnia; Shahryar Khoshtinat Nikkhoi; Azita Fakhravar; Mohsen Mehdiabdol; Hedieh Heydarzadeh; Saeed Ranjbar
Journal:  Mol Biol Rep       Date:  2019-04-01       Impact factor: 2.316

2.  The concurrent effects of azurin and Mammaglobin-A genes in inhibition of breast cancer progression and immune system stimulation in cancerous BALB/c mice.

Authors:  Payam Ghasemi-Dehkordi; Abbas Doosti; Mohammad-Saeid Jami
Journal:  3 Biotech       Date:  2019-06-18       Impact factor: 2.406

3.  An anti-cancer WxxxE-containing azurin polypeptide inhibits Rac1-dependent STAT3 and ERK/GSK-3β signaling in breast cancer cells.

Authors:  Zhe Zhang; Zhiyong Luo; Wenpu Min; Lin Zhang; Yaqun Wu; Xiaopeng Hu
Journal:  Oncotarget       Date:  2017-06-27

4.  Anticancer and antimicrobial potential of enterocin 12a from Enterococcus faecium.

Authors:  Preeti Sharma; Sumanpreet Kaur; Bhupinder Singh Chadha; Raminderjit Kaur; Manpreet Kaur; Sukhraj Kaur
Journal:  BMC Microbiol       Date:  2021-02-04       Impact factor: 3.605

5.  Therapeutic p28 peptide targets essential H1N1 influenza virus proteins: insights from docking and molecular dynamics simulations.

Authors:  Santanu Sasidharan; Vijayakumar Gosu; Donghyun Shin; Subhradip Nath; Timir Tripathi; Prakash Saudagar
Journal:  Mol Divers       Date:  2021-02-11       Impact factor: 3.364

Review 6.  Antiviral Peptides as Anti-Influenza Agents.

Authors:  Mariangela Agamennone; Marialuigia Fantacuzzi; Giovanni Vivenzio; Maria Carmina Scala; Pietro Campiglia; Fabiana Superti; Marina Sala
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.